We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$382M
AUM Growth
+$10.6M
Cap. Flow
-$9.98M
Cap. Flow %
-2.61%
Top 10 Hldgs %
41.14%
Holding
57
New
3
Increased
16
Reduced
26
Closed
2

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$8.37M
2
RTX icon
RTX Corp
RTX
+$3.76M
3
FISV
Fiserv Inc
FISV
+$1.99M
4
BDX icon
Becton Dickinson
BDX
+$1.64M
5
MDT icon
Medtronic
MDT
+$1.13M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$8.17M
2
ZBRA icon
Zebra Technologies
ZBRA
+$3.25M
3
VMW
VMware, Inc
VMW
+$2.99M
4
CDW icon
CDW
CDW
+$2.79M
5
ALSN icon
Allison Transmission
ALSN
+$1.18M

Sector Composition

Rank Sector Weight
1 Technology 25.99%
2 Healthcare 21.46%
3 Financials 14.46%
4 Consumer Staples 11.57%
5 Consumer Discretionary 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFC icon
26
Truist Financial
TFC
$63.9B
$6.65M 1.74%
219,028
+5,327
+2% +$165K
KO icon
27
Coca-Cola
KO
$383B
$5.64M 1.48%
93,720
– –
BRK.B icon
28
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.57M 1.46%
16,323
– –
AOS icon
29
A.O. Smith
AOS
$8.55B
$5.49M 1.44%
75,483
-1,841
-2% -$126K
PEP icon
30
PepsiCo
PEP
$196B
$5.41M 1.42%
29,231
-570
-2% -$106K
OTIS icon
31
Otis Worldwide
OTIS
$27.9B
$4.97M 1.3%
55,809
-758
-1% -$63.9K
ULTA icon
32
Ulta Beauty
ULTA
$21.8B
$4.77M 1.25%
10,131
-388
-4% -$190K
SEIC icon
33
SEI Investments
SEIC
$12.3B
$4.68M 1.23%
78,525
+1,614
+2% +$93.9K
HUM icon
34
Humana
HUM
$43.9B
$4.35M 1.14%
9,723
+607
+7% +$306K
LHX icon
35
L3Harris
LHX
$55.4B
$4.27M 1.12%
21,825
-1,221
-5% -$234K
WTW icon
36
Willis Towers Watson
WTW
$29.8B
$4.21M 1.1%
17,879
+4,600
+35% +$1.06M
RTX icon
37
RTX Corp
RTX
$290B
$3.76M 0.98%
+38,368
New +$3.76M
UNP icon
38
Union Pacific
UNP
$174B
$3.58M 0.94%
17,502
-210
-1% -$41.7K
SONY icon
39
Sony
SONY
$137B
$3.5M 0.92%
194,275
-5,390
-3% -$101K
CDW icon
40
CDW
CDW
$18.9B
$3.28M 0.86%
17,891
-15,949
-47% -$2.79M
WMT icon
41
Walmart Inc
WMT
$909B
$3.14M 0.82%
59,850
– –
CME icon
42
CME Group
CME
$95.4B
$2.38M 0.62%
12,849
-358
-3% -$66.2K
V icon
43
Visa
V
$677B
$2.33M 0.61%
9,828
-35,702
-78% -$8.17M
PFE icon
44
Pfizer
PFE
$143B
$2.22M 0.58%
60,652
-1,068
-2% -$41.6K
SNY icon
45
Sanofi
SNY
$107B
$2.13M 0.56%
39,578
-1,949
-5% -$105K
ABBV icon
46
AbbVie
ABBV
$465B
$1.65M 0.43%
12,242
– –
ABT icon
47
Abbott
ABT
$187B
$1.33M 0.35%
12,200
– –
UL icon
48
Unilever
UL
$142B
$1.23M 0.32%
21,013
-883
-4% -$52.4K
KHC icon
49
Kraft Heinz
KHC
$32.8B
$654K 0.17%
18,418
– –
PG icon
50
Procter & Gamble
PG
$340B
$536K 0.14%
3,532
– –
1
2
3

Similar funds

HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
PAMS
Pinpoint Asset Management (Singapore) Singapore $433M AUM 32.19% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $432M AUM 23% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Foyston, Gordon, & Payne's Q2 2023 Portfolio in Review

As of Q2 2023, Foyston, Gordon, & Payne held 57 positions worth $382M, up 2.8% from $372M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Foyston, Gordon, & Payne's Q2 2023 filing shows 3 new, 16 increased, 26 reduced and 2 closed positions. Its largest new stake was RTX Corp: 38,368 shares worth $3.76M. The largest sale was Visa, an estimated $8.17M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • Foyston, Gordon, & Payne's largest Q2 2023 buy was RTX Corp: 38,368 shares worth $3.76M.
  • Foyston, Gordon, & Payne added most to Novartis in Q2 2023, an estimated $8.37M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2023 reduction was Visa, cutting an estimated $8.17M.
  • Foyston, Gordon, & Payne fully exited Allegion in Q2 2023, selling an estimated $230K.
  • Foyston, Gordon, & Payne's ten largest holdings make up 41% of its $382M portfolio in Q2 2023.
  • Foyston, Gordon, & Payne opened 3 new positions and closed 2 in Q2 2023.
  • Foyston, Gordon, & Payne's portfolio value rose 2.8% quarter-over-quarter to $382M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2023, filed 1 Aug 2023.